Dermaheal Vitalizing Serum 40g
SKU : A1229
Available in stock
Dermaheal Vitalizing Serum 40g is a peptide treatment from Dermaheal. Supplied as 1 bottle x 40g per pack.
- sh-Oligopeptide-1 (EGF)
- Oligopeptide-24 (CG-EDP3)
- Acetyl Decapeptide-3 (Rejuline)
- Palmitoyl Pentapeptide-3
- Copper Tripeptide-1
- Camellia Sinensis Leaf Extract (Green Tea)
Product information
Dermaheal Vitalizing Serum 40g is a peptide treatment from Dermaheal. Supplied as 1 bottle x 40g per pack. It contains sh-Oligopeptide-1 (EGF) and Oligopeptide-24 (CG-EDP3). Manufactured by Caregen in South Korea. Available to verified clinics and certified practitioners with a Keypill trade account.
Get in touch
Questions about stock, batch documentation or trade pricing? Our team answers within one working day — and every registered clinic gets a named account manager who knows your order history.
Contact the right deskBlog
Latest in blog
Dermal fillers · · 4 min read
Injection planes, and why they decide what you stock
Subdermal, deep fat, supraperiosteal. The plane a product was formulated for is a manufacturing decision, and it is the reason a shelf of six fillers is not six interchangeable syringes.
Read article
Guidelines · · 4 min read
Receiving-desk paperwork: what to check before stock is used
Lot numbers, certificates of analysis and the importer of record each answer a different question about where a box came from. A minute at the desk, while the delivery is still a delivery.
Read article
Mesotherapy · · 4 min read
Polynucleotides and skinboosters order on different rhythms
Both are small syringes, both get filed under skin quality, and both end up on the same line of the stock sheet. They do not deplete at the same rate, and that is where the shortfall comes from.
Read article
Guidelines · · 4 min read
What a CE mark on the box does and does not tell you
It is a conformity marking, not a quality ranking. The information a buyer can actually use sits in the paperwork behind the mark rather than in the two letters printed on the carton.
Read article